Learn how your child's
Site Search
Showing 61 - 63 of 63 results
7 min read
The additional funding will support a Phase 2 clinical trial for an inhaled antisense oligonucleotide drug for people with cystic fibrosis who have the splicing mutation 3849+10Kb C-to-T.
Press Release
|
April 3, 2024
|
3 min read
Have questions about clinical trials? The Clinical Trial Navigator is a person who can help you get the answers you need.
1 min read